期刊文献+

微生物短杆菌(Brevibacterium sp.)选择性降解制备(R)-扁桃酸 被引量:2

Production of(R)-Mandelic Acid by Asymmetric Degradation of the Racemate with Brevibacterium sp.CCSYU10011
下载PDF
导出
摘要 以外消旋扁桃酸为底物,筛选出一株短杆菌Brevibacteriumsp.CCSYU10011,该菌能转化外消旋扁桃酸为(R)-扁桃酸.用全细胞转化法研究发现,其转化过程是不对称降解过程,即选择性降解了(S)-扁桃酸,进而获得(R)-扁桃酸.考察了温度、pH、底物浓度及细胞量等因素对(S)-扁桃酸降解的影响,转化结束后,收率为48.7%,对映体过量值(e.e.)可达99%. (R)-mandelic acid is a useful chiral synthon for the production of various pharmaceutical. In order to prepare (R)-mandelic acid from rac-mandelic acid, Brevibacterium sp. CCSYU10011 was screened from various microorganisms, of which the resting cells could convert the recreate to (R)-isomer. The process of bioconversion showed that the microorganism asymmetricly degraded (S)-mandelic acid from the racemate and (R)-mandelic acid was maintained. The factors affecting biotransformation efficiency were investigated, including temperature, pH, substrate concentration and cell biomass. Under the optimal conditions, 48.7% yield and 99% enantiomeric excess value were obtained.
作者 张辉 徐岩
出处 《过程工程学报》 EI CAS CSCD 北大核心 2006年第5期818-821,共4页 The Chinese Journal of Process Engineering
基金 国家重点基础研究发展规划(973)基金资助项目(编号:2003CB716008) 新世纪优秀人才支持计划资助项目 长江学者和创新团队发展计划资助项目(编号:IRT0532)
关键词 (R)-扁桃酸 不对称降解 全细胞转化 BREVIBACTERIUM sp. (R)-mandelic acid asymmetric degradation resting cell Brevibacterium sp.
  • 相关文献

参考文献19

  • 1Furlenmeier A,Quitt P,Vogler K,et al.6-Acyl Derivatives of Aminopenicillanic Acid[P].US Pat.:3957758,1976-05-18.
  • 2Yoshioka K,Harada S,Ochiai M,et al.Antibiotic Derivatives,Their Production and Use[P].US Pat.:4897489,1990-01-30.
  • 3Ferris M J.Arylethanolamine Derivatives,Their Preparation and Use in Pharmaceutical Compositions[P].US Pat.:4588749,1986-05-13.
  • 4Surivet J P,Vatèle J M.Total Synthesis of Antitumor Goniothalamus Styryllactones[J].Tetrahedron,1999,55:13011-13028.
  • 5Mills J,Schmiegel K K,Shaw W N.Phenethanolamines,Compositions Containing the Same,and Method for Effecting Weight Control[P].US Pat.:4391826,1983-07-05.
  • 6Sargent B J,Heal D J,Fernandez M I.Therapeutic Agents[P].US Pat.:5753665,1998-05-19.
  • 7Muto M.Material for Resolution of Optical Isomers,Its Preparation and Use[P].European Pat.:EP0098707,1984-01-18.
  • 8Franck J,Takahiko H,Tamizo K.Resolution of (±)-Mandelic-and (±)-2-(Chlorophenoxy) Propionic Acid Derivatives by Crystallization of Their Diastereomeric Amides with (R)-or (S)-α-Arylethylamines[J].Tetrahedron Lett,1999,40:2509-2512.
  • 9Yadav G D,Sivakumar P.Enzyme-catalysed Optical Resolution of Mandelic Acid via RS(±)-Methyl Mandelate in Non-aqueous Media[J].Biochem.Eng,2004,19:101-107.
  • 10Kaul P,Banerjee A,Mayilraj S,et al.Screening for Enantioselective Nitrilases:Kinetic Resolution of Racemic Mandelonitrile to (R)-(-)-Mandelic Acid by New Bacterial Isolates[J].Tetrahedron:Asymmetry,2004,15:207-211.

二级参考文献2

  • 1[1]Corson B.B.,et al..Orgnanic Synthesis[M].John Wiley:New York:1941,Collect.Voll.(Ⅰ):336.
  • 2[3]Aston J.G.,et al..Orgnanic Synthesis[M].John Wiley:New York:1955,Collect.Voll.(Ⅲ):538.

共引文献14

同被引文献28

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部